WhiteLab Genomics
WhiteLab Genomics uses AI to design genetic medicines and develop bio-assets for cell, RNA and DNA therapies.
$26MSeries B
LeadLoading investors…
Activity from announced rounds
WhiteLab Genomics uses AI to design genetic medicines and develop bio-assets for cell, RNA and DNA therapies.
Abstract provides a streaming security platform for real-time threat detection and response
Builds AI agents for institutional investors to surface market-moving signals in public markets
An open-source vector search engine.
Provides AI-native IP platform for enterprises to manage IP lifecycle
Develops secure software delivery for national security mission systems
Provides real-time API platform for Voice AI, speech-to-text, text-to-speech, and speech-to-speec...